Compumedics Ltd (CMP) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Compumedics Ltd (ASX:CMP), currently being evaluated. In 2025, Compumedics Ltd generated $51.04 Million in revenue and $467,000 in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Compumedics Ltd is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2025): $51.04 Million
- Free Cash Flow (2025): $467,000
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.